Actively Recruiting
Leuven Tolerogenic Protocol for Intestinal Transplantation
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-15
13
Participants Needed
1
Research Sites
1265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells. This protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.
CONDITIONS
Official Title
Leuven Tolerogenic Protocol for Intestinal Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients awaiting intestinal transplantation
You will not qualify if you...
- Living donation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Leuven
Leuven, Belgium, 3000
Actively Recruiting
Research Team
J
Jacques Pirenne, MD,PhD,MsC
CONTACT
L
Laurens J Ceulemans, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here